Smith et al. [88] demonstrated that the transcription factor (NF-κB) upregulates CD44 expression in triple-negative breast cancer cells, mainly via the interaction with the cis-regulatory element conserved region (CR1) located upstream of the CD44 promoter. The gene discussed is CD44; the disease is triple-negative breast carcinoma.